Osteogenesis Imperfecta Treatment Market

1

• Coherent Market Insights
• Market Research and Business Consulting Services
• https//www.coherentmarketinsights.com/
• COVID-19 Impact Tracker

2
OSTEOGENESIS IMPERFECTA TREATMENT MARKET
ANALYSIS

• Osteogenesis Imperfecta Treatment Market, by
  Drugs (Teriparatide, Denosumab, and Others) By
  Route of Administration (Subcutaneous,
  Intravenous, Oral, and Others), and by Region
  (North America, Latin America, Europe, Asia
  Pacific, Middle East, and Africa) - Size, Share,
  Outlook, and Opportunity Analysis, 2020 - 2027

3

• Osteogenesis imperfecta (OI) is a type of orphan
  disease group, characterized by varying degrees
  of skeletal fragility such as low bone mass and a
  propensity to fracture. This condition is caused
  due to the mutations in the COL1A1 or COL1A2 gene
  that encodes the alpha chains of collagen
  produced by osteoblasts. These genes are
  susceptible to different mutations for the
  production of fibrils.
• Osteogenesis Imperfecta Treatment Market - Impact
  of Coronavirus (Covid-19) Pandemic
• Osteogenesis imperfecta (OI) treatment market is
  adversely affected due to the outbreak of
  COVID-19, as it is becoming difficult for
  researchers to conduct researches during this
  pandemic. Though OI does not affect the immune
  system, lung connective tissue is distorted in
  all types of OI. The risk of pulmonary problems
  and severity of symptoms is high in people with
  abnormal chest shape, short stature, rib or
  vertebral fractures, and kyphoscoliosis

4
Impact of Coronavirus (Covid-19) Pandemic

• The osteogenesis imperfecta treatment market is
  estimated to be valued at US 684.2 million in
  2020 and is expected to rise at a CAGR of
  1.90 during the forecast period (2020-2027).

5
Figure 1. Osteogenesis Imperfecta Treatment
Market Share () Analysis, By Route of
Administration, 2020
6
Osteogenesis Imperfecta Treatment Market

• The non-availability of effective treatment for
  osteogenesis imperfecta is expected to hinder the
  market growth during the forecast period.
  Moreover, the shortage of trained professionals
  in some low- and middle-income countries is
  likely to hamper the market growth.

7
(No Transcript)
8

• Osteogenesis Imperfecta Treatment Market
  Regional Analysis
• Europe region accounted for the largest share in
  the osteogenesis imperfecta treatment market in
  2019, owing to increasing focus of key players on
  research development and rise in the number of
  clinical trials for the treatment of osteogenesis
  imperfecta. For instance, Bone Therapeutics SA
  received an Orphan Drug designation from the
  Europe Medicines Agency (EMA) as well as the FDA
  for ALLOB, which is an allogeneic bone cell
  therapy product for osteogenesis imperfect
  treatment. A product with Orphan Drug designation
  recevies certain incentives and benefits along
  with a period of 10 years market exclusivity,
  protocol assistance, and reduced regulatory fees
  upon approval.

9
Figure 2. Osteogenesis Imperfecta Treatment
Market Value (US Mn) Y-o-Y Growth (),
2017-2027
10

• Osteogenesis Imperfecta Treatment Market -
  Competitive Landscape
• Key players operating in the osteogenesis
  imperfecta treatment market include Bone
  Therapeutics SA, Mereo BioPharma Group plc,
  Celgene Corporation, Eli Lilly and Company, Cipla
  Inc., Amgen Inc, Sun Pharmaceutical Industries
  Limited, Mylan N.V., Teva Pharmaceutical
  Industries Ltd, Merck Co., Inc., Jubilant Life
  Sciences Ltd., Aurobindo Pharma, and Genzyme
  Corp.

11

• Request Sample Report
• Request Customization
• Download PDF Brochure
• Talk to Analyst
• Buy Now
• Reference https//www.coherentmarketinsights.com/m
  arket-insight/osteogenesis-imperfecta-treatment-ma
  rket-4064

12
About Us

• Coherent Market Insights is a global market
  intelligence and consulting organization focused
  on assisting our plethora of clients achieve
  transformational growth by helping them make
  critical business decisions.
• What we provide
• Customized Market Research Services
• Industry Analysis Services
• Business Consulting Services
• Market Intelligence Services
• Long term Engagement Model
• Country Specific Analysis

13
Contact Us

• Mr. Shah
• Coherent Market Insights Pvt.Ltd.
• Address 1001 4th Ave, 3200 Seattle, WA 98154,
  U.S.
• Phone [phone]
• Email sales_at_coherentmarketinsights.com

14

• Thank You!
• Kindly follow CMI Social Media
  Profiles for the latest company updates
• Facebook
• Linkedin
• Twitter
• https//www.coherentmarketinsights.com/